Akzo Nobel NV is a holding company, which engages in the manufacture and sale of coating and paint products. engages in the production and marketing of paints and coatings. It operates through the following segments: Decorative Paintings, Performance Paintings, and Corporate and Others. The Decorative Paints segment manufactures and supplies a range of interior and exterior decoration and protection products for professional and do-it-yourself markets. The Performance Coatings segment produces automotive and aerospace; industrial; marine and protective; and powder coatings. The company was founded in 1792 and is headquartered in Amsterdam, Netherlands.

MaxiVAX is a Swiss clinical-stage biotechnology company, currently performing a first-in-man (phase I) trial in various tumours with MVX-ONCO-1. MaxiVAX’ mission is to develop alternative solutions to “established cancer therapies” that are more effective, are personalized and enable the patient to fight his own disease. MaxiVAX’ first treatment, MVX-ONCO-1 has been classified as an Advanced Therapeutic Product by the European Medicines Agency. The resulting approval procedure is different than that of a traditional drug and should generally allow a faster development until market approval with fewer and less extensive clinical trials.

Vaccinogen manufactures vaccines and other immunotherapeutic products for cancers and infectious diseases. It operates as a biotechnology company that develops OncoVAX, an Active Specific Immunotherapy (ASI) vaccine which uses the patient's own cancer cells to block the return of colon cancer following surgery. The company was incorporated in 2007 and is based in Frederick, Maryland.

The Institute for Biomathematics and Biometry conducts fundamental research in areas including Epidemiology, Analysis of Complex Experimental Data, Analysis of Environmental Chemicals, Machine Learning, Bacterial Communication Processes in the Rhizosphere, the Regulation Pathway of NF-κB and Coagulation Cascades.

Novo Nordisk A/S is a global healthcare company, which engages in the the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Biopharm segments. The Diabetes and Obesity Care segment includes insulin, GLP-1 and related delivery systems, oral antidiabetic products (OAD), obesity, and other serious chronic diseases. The Biopharm segment focuses on rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1925 is headquartered in Bagsværd, Denmark.

Beijing Zhikang Boyao Oncology Research Co. Ltd. operates medical oncology center for chemotherapy cancer patients. It engages in the research and development for cancer treatment and tumor transplantation through i-graft tumor transplantation model. The company was founded by Chen Yi You in December 2012 and is headquartered in Beijing, China.

AltaRex Medical Corp., a subsidiary of Endo International Plc, is a Canadian company located in Edmonton, AB, that develops and research foreign antibodies for cancer and life-threatening disease treatment. It was acquired by ViRexx Medical Corp., now a subsidiary of Endo International Plc on December 13, 2004 for $22.66 million.

Genetics Institute is a U.S. based biotechnology research and development company. The company developed drugs such as Neumega and Recombinate used in the prevention of severe reductions in the number of blood clotting cells. The company was founded in 1980 by Thomas Maniatis and Mark Ptashne, and started off by operating out of Ptashne’s home. Genetics Institute was acquired by Wyeth in 1992 and operates as part of Wyeth’s research division.

Genecraft GmbH is a German private company that provides nucleotides, kits and mixtures for molecular biology products.

Sidney Kimmel Cancer Center, a subsidiary of Sanford Burnham Prebys Medical Discovery Institute, is a company headquartered in San Diego, CA, that provides medical research services. It was acquired by Sanford Burnham Prebys Medical Discovery Institute on June 23, 2009 for $25 million.

Xiamen Lujia Biotechnology Co., Ltd., established on 2001-07-06, Business scope includes general items:New material technology research and development;Research and development of bio-based materials technology;Sales of bio-based materials;Healthy food(prepackaged)Sales;Food Additive Sales;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Sales of formula food for special medical purposes;Food import and export;food sales(Only sell prepackaged food);internet sales(Except for products that require a license for sale);Domestic trade agent;Technology Import and Export;Import and export;Import and export agency.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:Inspection and testing service;Food Internet Sales;food sales;Drug import and export.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)(The above business projects do not include projects within the scope of special management measures for foreign investment access)

Gradalis is a late stage biotechnology company focused on the development and commercialization of novel personalized therapeutics to treat cancer. We are developing Vigil, our proprietary immunotherapy platform in multiple advanced cancer indications with the lead program for the treatment of patients with Ewing's sarcoma.

Yuetenong Biotechnology Hebei Co., Ltd., established on 2020-01-19, Business scope includes biological products,Cell Engineering Technology,cell therapy technology,cell antibody,cell storage technology,genetic testing technology,gene therapy technology,gene medicine technology,Research and development of anticancer drugs,Production(Prohibited,Except for restricted items)and technical applications;Research and Development of Biologics,Production(Prohibited,Except for restricted items)and sales;Laboratory equipment and consumables,medical instruments,Chemical Products(Hazardous chemicals and other pre-administrative licensing items are not included)production(Prohibited,Except for restricted items)and sales;Biotechnology Consulting and Transfer;Import and export of goods or technology(Except for the import and export of goods and technologies that are prohibited by the state or involve administrative approval).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

The Board of Trustees of the University of Illinois, part of University of Illinois, is a company headquartered in Urbana, IL, that trusts Except Educational Religious.

Urodelia SA develops immunotherapy method to treat cancer in pets. The company was founded by Nicole Rouquet, Patrick Landanger and Patrick Frayssinet in 2003 and is headquartered in Saiguede, France.

Agalimmune Ltd., a subsidiary of BioLineRx Ltd., is a British company located in London that develops anti-cancer immunotherapy technology. It was founded by Graham Griffiths. Mike Westby is currently the CEO of the firm. BioLineRx Ltd. acquired Agalimmune Ltd. on March 23, 2017 for $6.05 million.